The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
As of December 2023 Amgen has a market cap of $144.15 Billion. This makes Amgen the world's 82th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $144.15 B | 2.86% |
2022 | $140.13 B | 10.59% |
2021 | $126.71 B | -5.33% |
2020 | $133.85 B | -6.11% |
2019 | $142.56 B | 16.32% |
2018 | $122.56 B | -2.91% |
2017 | $126.23 B | 16.06% |
2016 | $108.76 B | -11.13% |
2015 | $122.39 B | 1.05% |
2014 | $121.12 B | 40.7% |
2013 | $86.08 B | 32.05% |
2012 | $65.19 B | 15.83% |
2011 | $56.28 B | 10% |
2010 | $51.16 B | -9.1% |
2009 | $56.28 B | -6.91% |
2008 | $60.46 B | 19.78% |
2007 | $50.48 B | -36.62% |
2006 | $79.64 B | -17.48% |
2005 | $96.52 B | 19.42% |
2004 | $80.82 B | 1.9% |
2003 | $79.31 B | 27.29% |
2002 | $62.31 B | 5.57% |
2001 | $59.02 B |
On Dec 6th, 2023 the market cap of Amgen was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $377.02 B | 161.55% | ๐บ๐ธ USA |
![]() Pfizer PFE | $162.56 B | 12.77% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $258.43 B | 79.29% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $559.37 B | 288.05% | ๐บ๐ธ USA |
![]() Biogen BIIB | $33.88 B | -76.49% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $98.88 B | -31.40% | ๐บ๐ธ USA |
![]() Illumina ILMN | $18.10 B | -87.44% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $101.49 B | -29.59% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $75.20 B | -47.83% | ๐ฌ๐ง UK |